Original Research
Published on 08 Sep 2017
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2017.01100
- 5,307 views
- 9 citations
